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LETTERS TO THE EDITORLow Birth Weight: Intrauterine Growth
Restriction or Prematurity?To the Editor:
With great interest we read the article from Eriksson
et al1 confirming the relation between low birth weight
and adult chronic kidney disease (CKD). The Helsinki
Birth Cohort Study forms a unique cohort given its large
size and extensive follow-up. Linking this cohort with
International Classification of Diseases codes and different reg-
istries, the authors found a significant hazard ratio (HR)
of 0.8 for every additional standard deviation in birth
weight on the outcome of CKD. Second, a significant HR
of 2.6 for CKD risk was reported for adults born before
34 weeks of gestational age compared with those born at
term.
Nonetheless, it remains unclear whether the association
between birth weight and CKD resulted from prematurity,
low birth weight for gestational age, or the combination.
The authors state that a low nephron number as a result of
prematurity could be responsible for the increased CKD
risk.2 However, other studies have mentioned an increased
risk for hypertensive disease in those born after intra-
uterine growth restriction (based on birth weight per-
centiles),3,4 which could in turn be responsible for an
increased risk for CKD and end-stage renal disease.5
Consequently, it seems appropriate, if possible, to correct
the analyses in Tables 2 and 4 of the article for con-
founding by gestational age at birth and use birth weight
percentiles instead of absolute values.5 This might help
solve the question of whether intrauterine growth re-
striction or prematurity is more strongly related to CKD in
later life.
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Soc Nephrol. 2008;19(1):151-157.In Reply to ‘Low Birth Weight: Intrauterine
Growth Restriction or Prematurity?’We thank Drs Kooiman, Terstappen, and Lely1 for their
interest and for giving us this opportunity to provide more
data from the Helsinki Birth Cohort Study.2
Following their suggestion, we constructed a sex- and
gestational age–adjusted standardized score for each birth
weight. Table 1 shows hazard ratios (HRs) for chronic
kidney disease (CKD). The first 2 rows repeat data from
our published article.2 There is little evidence for associ-
ation with gestational age. The HR for 1 standard deviation
of birth weight is 0.82 (95% confidence interval,
0.74-0.91; P < 0.001), mostly due to the association
observed in men. The new gestation-adjusted birth weight
has a much more attenuated association with CKD, which
remains more negative among men. Using gestation and
the gestation-adjusted birth weight in combination enables
reconstruction of the absolute birth weight. In the joint
model, the gestation-adjusted variable has a somewhat
weaker HR for CKD than that obtained from birth weight
alone.
Table 4 of our article2 illustrates the absence of associ-
ation with gestational age overall, but shows the high HRs
for CKD in both men and women born before 34
completed weeks, as highlighted by Kooiman et al.
However, <1% of the surviving Helsinki Birth Cohort
Study members are born this early, making the fraction of
CKD attributable to this exposure small in this population.
It may be somewhat larger in populations born today. For
example, 2.7% of all US infants are born before 34 weeks,3
and >99% of them survive infancy.
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Table 1. Association of Neonatal Measurements and Kidney Disease
Neonatal Measurement
(Standardized Units)
Men and Women Men Women P for
InteractionHR 95% CI P HR 95% CI P HR 95% CI P
As in published table
Gestational age 0.99 0.89-1.10 0.8 0.95 0.83-1.09 0.4 1.05 0.89-1.24 0.6 0.4
Birth weight 0.82 0.74-0.91 <0.001 0.73 0.64-0.83 <0.001 0.99 0.84-1.16 0.9 0.004
New analyses
Gestation-adjusted birth weight 0.98 0.90-1.07 0.7 0.90 0.79-1.01 0.08 1.08 0.97-1.21 0.2 0.02
Joint model
Gestational age 0.98 0.88-1.09 0.7 0.92 0.80-1.06 0.3 1.05 0.89-1.24 0.5 0.3
Gestation-adjusted birth weight 0.87 0.79-0.97 0.009 0.78 0.68-0.89 <0.001 1.03 0.88-1.20 0.8 0.01
Note: The Cox model is stratified on combinations of sex and year of birth and also includes early-life and adult socioeconomic status.
Abbreviations: CI, confidence interval; HR, hazard ratio.Publication Information: © 2018 by the National Kidney Founda-
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Accessed February 1, 2018.910Thoracic Ultrasound Artifacts: Still a
Matter of DiscussionTo the Editor:
We enjoyed the exhaustive narrative review by Covic
et al.1 We particularly appreciated the caution expressed
regarding clinical interpretation of B-lines, which are lung
ultrasound artifacts, because many recent articles have
endorsed the validity of counting artifacts for the diagnosis
of pulmonary edema or any extravascular lung water. This
is troubling because such findings lack disease specificity.2
Whatever the cause, B-lines are mostly generated when the
ultrasound beam crosses areas of difference in acoustic
impedance (chest wall vs air) that reduce the propagation
speed of the ultrasound beam. Manufacturers’ calibration
of ultrasound devices is usually based solely on the speed
of sound in tissues of the chest wall (w1,500 m/s),
whereas the propagation speed is much lower in other
structures within the chest (w400 m/s air in the inter-
stitium, bronchi, vessels, and lymphatic tissue).3 More-
over, these artifacts may be affected by heart and
respiratory movements, the thickness of subcutaneous
tissue due to fat and edema, and emphysema. These
artifacts are detectable even in the postpneumonectomyspace, containing residual air, liquid films and/or edema,
and scar tissue. Their detection can also be modified by
an increase in the pleural line movement rate in dyspneic
patients and by concomitant heart and lung disorders.4
Consequently, the detection of B-lines remains
largely subjective and at best semiquantitative, and it is
questionable whether a firm relationship between the
number of B-lines and a specific disease can be established.5
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